ICU Equipment in Colorado

Patient Shield Concepts LLC manufactures SuctionShield, a disposable, single-patient suction holster designed to prevent healthcare-associated infections (HAIs) in critical care settings. SuctionShield holds Yankauer suction tips and other oral suction implements securely on hospital bed rails, operating tables, and gurneys, allowing tips to air-dry and preventing cross-contamination and droplet transmission. FDA-approved for 24-hour use, the product features a patented adjustable strap, bright orange visibility, and a raised grid base that prevents suction tips from resting in accumulated secretions. Suitable for use in ORs, ICUs, EDs, PACUs, LTACs, skilled nursing facilities, and rehabilitation settings. The device addresses the clinical and economic impact of HAIs—which affect 1 in 31 hospitalized patients at costs exceeding $25,000–$80,000 per infection—offering a cost-effective solution at only a few dollars per use. Manufactured from FDA-approved materials and fully recyclable.

Securisyn Medical develops innovative airway management and securement devices designed to enhance airway safety, prevent unplanned extubation, and reduce associated clinical complications. The company's core focus is on endotracheal tube stabilization solutions for both adult and pediatric populations, including neonatal applications. Their flagship product, SolidAIRity® Flex, targets adult airway securement with applications across ICU, operating room, and field trauma environments. Securisyn's approach emphasizes patient safety, practitioner confidence, and healthcare cost reduction through evidence-based device design and clinical validation. The company is committed to sustainable, ethical business practices while advancing ventilator safety standards and airway management protocols across acute care settings.

THE SURGICAL COMPANY INTERNATIONAL BV (TSC Life) is a global medical device manufacturer specializing in temperature management systems, fluid and blood warming devices, and single-use bronchoscopes for operating rooms, intensive care units, and emergency departments. The company's core product portfolio includes the Broncoflex® line of single-use bronchoscopes (including the XFlo variant with enhanced working channels for diagnostic and therapeutic procedures), Mistral-Air® forced-air warming systems, and Fluido® blood and fluid warming devices (Fluido Compact, Fluido AirGuard System, Fluido Irrigation). These solutions address patient safety through normothermia maintenance and cross-contamination prevention across surgical, critical care, emergency, and urological settings. TSC Life operates internationally from Amsterdam, The Netherlands, with US customer service and multiple distribution partners. The company emphasizes evidence-based design, infection control benefits through single-use construction, and workflow efficiency. Products serve pulmonologists, intensivists, anesthesiologists, and surgical teams in high-acuity environments including trauma, cardiac surgery, and complex oncology procedures. The company has received FDA clearance for pediatric use of the Fluido Compact system and maintains commitment to sustainable, accessible healthcare delivery with a target to reach 25 million patients annually.

SeaStar Medical is a clinical-stage immunotherapy company developing the Selective Cytopheretic Device (SCD), a patented therapeutic platform designed to treat destructive hyperinflammatory responses in critically ill patients. The SCD selectively targets and neutralizes highly activated neutrophils and monocytes responsible for cytokine storms—uncontrolled inflammatory cascades triggered by trauma, infection, or surgery that can lead to multiorgan failure and death in ICU settings. The device integrates seamlessly into existing hemodialysis delivery systems, offering a disease-modifying approach to restore immune balance without requiring standalone infrastructure. SeaStar's technology addresses a significant clinical gap: there are currently no FDA-approved therapeutic options specifically designed to calm hyperinflammation in this patient population. The company's clinical evidence supports that SCD therapy may reduce ICU length of stay, decrease dialysis dependency, and improve survival outcomes. The device is positioned for use in critical care and intensive care units treating sepsis, post-surgical complications, and trauma-induced inflammatory responses. SeaStar Medical is headquartered in Denver, Colorado, and is focused on advancing the critical-care treatment paradigm through robust scientific validation and regulatory pathways.